MicroSert
MicroSert Ltd. is developing an intraocular implant for the treatment of chronic eye diseases such as AMD and DME. AMD and DME, both leading causes of blindness, are treated with monthly Intravitreal injections (insertion of a needle into the eye) of Lucentis or Avastin. Extremely non patient-friendly, involves safety issues and delivers a peak drug concentration.
Industries
health-care
medical-device
Nr. of Employees
small (1-50)
Patents
Implantable drug delivery device and a system and method for deployment of such devices
US-10376413-B2
View DetailsMiniature implanted drug delivery devices and inserter systems for introducing such devices
US-8992503-B2
View Details
Implantable drug delivery device and a system and method for deployment of such devices
US-10376413-B2
View DetailsMiniature implanted drug delivery devices and inserter systems for introducing such devices
US-8992503-B2
View Details